logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Therapeutic Area
    3. Neurology & Sleep

    Neurology & Sleep drugs

    FiltersReset Filters
    74 results

    • abilify asimtufii

      (Aripiprazole)
      Otsuka America Pharmaceutical, Inc
      Usage: ABILIFY ASIMTUFII is indicated for the treatment of schizophrenia in adults and for maintenance monotherapy of bipolar I disorder in adults.

    • abilify maintena

      (aripiprazole)
      Otsuka America Pharmaceutical, Inc.
      Usage: ABILIFY MAINTENA (aripiprazole) is indicated for the treatment of schizophrenia and as maintenance monotherapy for bipolar I disorder in adults.

    • aimovig

      (erenumab-aooe)
      Amgen Inc
      Usage: AIMOVIG is indicated for the preventive treatment of migraines in adults.

    • ambien

      (zolpidem tartrate)
      sanofi-aventis U.S. LLC
      Usage: AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia, specifically for difficulties with sleep initiation. It effectively reduces sleep latency for up to 35 days, as demonstrated in controlled clinical studies lasting 4–5 weeks.

    • ambien

      (zolpidem tartrate)
      sanofi-aventis U.S. LLC
      Usage: AMBIEN CR (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia, particularly for difficulties with sleep onset and/or maintenance, as measured by wake time after sleep onset. Clinical trials supporting its efficacy lasted up to 24 weeks.

    • amvuttra

      (VUTRISIRAN)
      Alnylam Pharmaceuticals, Inc.
      Usage: AMVUTTRA is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.

    • apokyn

      (APOMORPHINE HYDROCHLORIDE)
      MDD US Operations, LLC
      Usage: APOKYN (apomorphine hydrochloride injection) is indicated for the acute, intermittent treatment of hypomobility during "off" episodes in advanced Parkinson's disease, including "end-of-dose wearing off" and unpredictable "on/off" episodes. It is studied as an adjunct to other medications.

    • aptiom

      (ESLICARBAZEPINE ACETATE)
      Sumitomo Pharma America, Inc.
      Usage: APTIOM is used to treat partial-onset seizures in patients aged 4 years and older.

    • aubagio

      (teriflunomide)
      Genzyme Corporation
      Usage: AUBAGIO® is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

    • austedo

      (Deutetrabenazine)
      Teva Neuroscience, Inc.
      Usage: AUSTEDO XR and AUSTEDO are indicated for the treatment of chorea associated with Huntington's disease and tardive dyskinesia in adults.
      • ...